Genmab Stock News & Updates
[WKN: 565131 | Symbol: GE9]
Hope bearer in oncology: Genmab impresses with Phase 2 data on Petosemtamab
Strong response rates: In combination with standard chemotherapy, Petosemtamab achieves response...
Genmab A/S: Analysts React Positively to the Completion of the Merus Acquisition
Genmab A/S is a pharmaceutical company that operates as a highly specialized innovation hub for antibody...
- ‹
- 1
- ›